• 1
    Eyre DW, Golubchik T, Gordon NC et al. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2012; 2: e001124.
  • 2
    Didelot X, Bowden R, Wilson DJ, Peto TE, Crook DW. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet 2012; 13: 601612.
  • 3
    Price J, Didelot X, Crook DW, Llewelyn MJ, Paul J. Whole genome sequencing in the prevention and control of Staphylococcus aureus infection. J Hosp Infect 2012; DOI: 10.1016/j.jhin.2012.10.003.
  • 4
    Ogston A. Micrococcus poisoning. J Anat Physiol 1882; 17: 2458.
  • 5
    Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309317.
  • 6
    Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 2000; 30: 454460.
  • 7
    Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ 2006; 333: 281284.
  • 8
    Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 14181423.
  • 9
    van Belkum A, Tassios PT, Dijkshoorn L et al. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 2007; 13 (suppl 3): 146.
  • 10
    Holden MT, Feil EJ, Lindsay JA et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 2004; 101: 97869791.
  • 11
    Lindsay JA, Holden MT. Staphylococcus aureus: superbug, super genome? Trends Microbiol 2004; 12: 378385.
  • 12
    Kuroda M, Ohta T, Uchiyama I et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001; 357: 12251240.
  • 13
    Bloemendaal AL, Brouwer EC, Fluit AC. Methicillin resistance transfer from Staphylococcus epidermidis to methicillin-susceptible Staphylococcus aureus in a patient during antibiotic therapy. PLoS One 2010; 5: e11841.
  • 14
    Levine DP. Vancomycin: a history. Clin Infect Dis 2006; 42 (suppl 1): S5S12.
  • 15
    Kos VN, Desjardins CA, Griggs A et al. Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with methicillin-resistant S. aureus hospital-acquired infection in the United States. MBio 2012; 3; doi:10.1128/mBio.00112-12.
  • 16
    Renzoni A, Andrey DO, Jousselin A et al. Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureus. PLoS One 2011; 6: e21577.
  • 17
    Howden BP, Stinear TP, Allen DL, Johnson PDR, Ward PB, Davies JK. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52: 37553762.
  • 18
    Mwangi MM, Wu SW, Zhou Y et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci USA 2007; 104: 94519456.
  • 19
    Peleg AY, Miyakis S, Ward DV et al. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus. PLoS One 2012; 7: e28316.
  • 20
    Köser CU, Holden MT, Ellington MJ et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 2012; 366: 22672275.
  • 21
    Nonhoff C, Rottiers S, Struelens MJ. Evaluation of the Vitek 2 system for identification and antimicrobial susceptibility testing of staphylococcal spp. Clin Microbiol Infect 2005; 11: 150153.
  • 22
    Falush D, Bowden R. Genome-wide association mapping in bacteria? Trends Microbiol 2006; 14: 353355.
  • 23
    Baba T, Takeuchi F, Kuroda M et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002; 359: 18191827.
  • 24
    McAdam PR, Holmes A, Templeton KE, Fitzgerald JR. Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient. PLoS One 2011; 6: e24301.
  • 25
    Young BC, Golubchik T, Batty EM et al. Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc Natl Acad Sci USA 2012; 109: 45504555.
  • 26
    Harris SR, Feil EJ, Holden MT et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010; 327: 469474.
  • 27
    Wenzel RP, Reagan DR, Bertino JSJ, Baron EJ, Arias K, Bertino JS Jr. Methicillin-resistant Staphylococcus aureus outbreak: a consensus panel's definition and management guidelines. Am J Infect Control 1998; 26: 102110.
  • 28
    McAdam PR, Templeton KE, Edwards GF et al. Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2012; 109: 91079112.
  • 29
    Wyllie D, Paul J, Crook D. Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control. J Antimicrob Chemother 2011; 66: 26852688.
  • 30
    Lindsay JA, Moore CE, Day NP et al. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol 2006; 188: 669676.
  • 31
    Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002; 99: 76877692.
  • 32
    Kennedy AD, Otto M, Braughton KR et al. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci USA 2008; 105: 13271332.
  • 33
    Carpaij N, Willems RJ, Rice TW et al. Genetic variation in spatio-temporal confined USA300 community-associated MRSA isolates: a shift from clonal dispersion to genetic evolution? PLoS One 2011; 6: 6.
  • 34
    Vogel V, Falquet L, Calderon-Copete SP, Basset P, Blanc DS. Short term evolution of a highly transmissible methicillin-resistant Staphylococcus aureus clone (ST228) in a tertiary care hospital. PLoS One 2012; 7: e38969.
  • 35
    Feng Z, Chakraborty D, Dewell SB, Reddy BV, Brady SF. Environmental DNA-encoded antibiotics fasamycin A and B inhibit FabF in type II fatty-acid biosynthesis. J Am Chem Soc 2012; 134: 29812987.